期刊文献+

芬太尼透皮贴剂对比吗啡治疗中重度癌痛的系统评价 被引量:9

Transdermal Fentanyl versus Morphine for Moderate/Severe Cancer Pain:A Systematic Review
原文传递
导出
摘要 目的系统评价芬太尼透皮贴剂对比口服吗啡治疗中重度癌痛的效果。方法计算机检索h e Cochrane Library(2014年第1期)、Pub Med、Web of Science、CNKI、VIP、CBM和Wan Fang Data数据库,纳入芬太尼透皮贴剂对比口服吗啡治疗中重度癌痛的随机对照试验(RCT),检索时限截至2014年1月。由2位研究者按照纳入与排除标准独立进行文献筛选、资料提取和评价纳入研究的方法学质量后,采用Rev Man 5.1.0软件进行Meta分析。结果共纳入35个RCT,3 406例患者。Meta分析结果显示,芬太尼透皮贴剂与口服吗啡镇痛效果差异无统计学意义[OR=1.00,95%CI(0.80,1.27),P=0.99]。与口服吗啡相比,芬太尼透皮贴剂组患者的便秘、恶心呕吐、嗜睡和尿潴留的发生率明显较低(P<0.05),但皮肤刺激症状发生率明显增高(P<0.05)。结论芬太尼透皮贴剂在治疗中重度癌痛方面效果与口服吗啡相当,且不良反应更少。但受纳入研究质量的限制,本研究结论尚需进一步开展更多高质量的RCT进行验证。 Objective To systematically review the efficacy of transdermal fentanyl versus oral morphine for mod- erate/severe cancer pain. Methods Databases such as The Cochrane Library (Issue 1, 2014), PubMed, Web of Science, CNKI, VIP, CBM and WanFang Data were searched for randomized controlled trials (RCTs) on the efficacy of transdermal fentanyl versus oral morphine for moderate/severe cancer pain up to January 2014. According to inclusion and exclusion criteria, two reviewers independently screened literature, extracted data, and assessed methodological quality of included studies. Then meta-analysis was performed using RevMan 5.1.0 software. Results A total of 35 RCTs involved 3 406 patients were included. The results of meta-analysis showed that, there was no significant difference in effectiveness between transdermal fentanyl and oral morphine for moderate/severe cancer pain (OR=1.00, 95%CI 0.80 to 1.27, P=0.99). Compared with oral morphine, transdermal fentanyl was better in lowering the incidences of constipation, nausea and vomiting, lethargy and urinary retention; but transdermal fentanyl increased the incidences of skin rashes and itch (P〈0.05). Conclusion Transdermal fentanyl is as effective as oral morphine in the treatment of moderate/severe cancer pain, and transdermal fentanyl causes less side effects. Due to poor quality of the included studies, the above conclusion should be verified by further conducting more high quality RCTs.
出处 《中国循证医学杂志》 CSCD 2014年第11期1380-1388,共9页 Chinese Journal of Evidence-based Medicine
关键词 芬太尼透皮贴剂 吗啡 癌痛 系统评价 META分析 随机对照试验 Transdermal fentanyl Oral morphine Cancer pain Systematic review Meta-analysis Randomizedcontrolled trial
  • 相关文献

参考文献45

  • 1Cleary JF. The pharmacologic management of cancer pain. J Palliat Med, 2007, 10(6): 1369-1394.
  • 2Wiffen PJ, Wee B, Moore RA. Oral morphine for cancer pain. Cochrane Database Syst Rev, 2013, 7: Cd003868.
  • 3Cachia E, Ahmedzai SH. Transdermal opioids for cancer pain. Curr Opin Support Palliat Care, 2011, 5(1): 15-19.
  • 4Jeal W, Benfield P. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control. Drugs, 1997, 53(1): 109-138.
  • 5Muijsers RB, Wagstaff AJ. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs, 2001, 61(15): 2289-2307.
  • 6Kornick CA, Santiago-Palma J, Moryl N, et al. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain. Drug Saf, 2003, 26(13): 951-973.
  • 7Higgins JPT, Green S (editors). Cocbrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: www, cochrane-hand- book.org.
  • 8Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage, 1997, 13(5): 254-261.
  • 9Wong JO, Chiu GL, Tsao CJ, et al. Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain. Acta Anaesthesiol Sin, 1997, 35(1): 25-32.
  • 10何建萍,禹正杨,朱肖奇,鄢希,任莉,易成,谢名英.芬太尼透皮贴剂治疗癌症疼痛的临床观察[J].中国肿瘤临床,2002,29(11):823-824. 被引量:2

二级参考文献109

共引文献215

同被引文献110

引证文献9

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部